UMMS Affiliation
Division of Preventive and Behavioral Medicine
Publication Date
2019-05-01
Document Type
Article
Disciplines
Dermatology | Diagnosis | Epidemiology | Musculoskeletal Diseases | Skin and Connective Tissue Diseases
Abstract
BACKGROUND: Despite increasing awareness of the disease, rates of undiagnosed psoriatic arthritis (PsA) are high in patients with psoriasis (PsO). The validated Psoriasis Epidemiology Screening Tool (PEST) is a five-item questionnaire developed to help identify PsA at an early stage.
OBJECTIVES: To assess the risk of possible undiagnosed PsA among patients with PsO and characterize patients based on PEST scores.
METHODS: This study included all patients enrolled in the Corrona PsO Registry with data on all five PEST questions. Demographics, clinical characteristics and patient-reported outcomes were compared in Corrona PsO Registry patients with PEST scores > /=3 and < 3 using t-tests for continuous variables and chi-squared tests for categorical variables; scores > /=3 may indicate PsA.
RESULTS: Of 1516 patients with PsO, 904 did not have dermatologist-reported PsA; 112 of these 904 patients (12.4%) scored > /=3 and were significantly older, female, less likely to be working, and had higher BMI than patients with scores < 3. They also had significantly longer PsO duration, were more likely to have nail PsO and had worse health status, pain, fatigue, Dermatology Life Quality Index and activity impairment.
CONCLUSIONS: Improved PsA screening is needed in patients with PsO because the validated PEST identified over one-tenth of registry patients who were not noted to have PsA as having scores > /=3, who could have had undiagnosed PsA. Appropriate, earlier care is important because these patients were more likely to have nail PsO, worse health-related quality of life and worse activity impairment.
Rights and Permissions
© 2019 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
DOI of Published Version
10.1111/jdv.15443
Source
J Eur Acad Dermatol Venereol. 2019 May;33(5):886-892. doi: 10.1111/jdv.15443. Epub 2019 Mar 5. Link to article on publisher's site
Journal/Book/Conference Title
Journal of the European Academy of Dermatology and Venereology : JEADV
Related Resources
PubMed ID
30663130
Repository Citation
Mease, P. J.; Palmer, J. B.; Hur, P.; Strober, B. E.; Lebwohl, M.; Karki, C.; Reed, G. W.; Etzel, C. J.; Greenberg, J. D.; and Helliwell, P. S., "Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry" (2019). Open Access Articles. 3795.
https://escholarship.umassmed.edu/oapubs/3795
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Included in
Dermatology Commons, Diagnosis Commons, Epidemiology Commons, Musculoskeletal Diseases Commons, Skin and Connective Tissue Diseases Commons